nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

30.10.2018 | Letter to the Editor

Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer

verfasst von: Eric Laffon, Roger Marthan

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

Sir, …

Kirchner J, Sawicki LM, Nensa F, Schaarschmidt BM, Reis H, Ingenwerth M, et al. Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-4109-x.

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRef

Laffon E, Calcagni ML, Galli G, Giordano A, Capotosti A, Marthan R, et al. Comparison of three-parameter kinetic model analysis to standard Patlak's analysis in 18F-FDG PET imaging of lung cancer patients. EJNMMI Res. 2018;8:24–32.CrossRef

Dournes G, Grodzki D, Macey J, Girodet PO, Fayon M, Chateil JF, et al. Quiet submillimeter MR imaging of the lung is feasible with a PETRA sequence at 1.5 T. Radiology. 2015;276:258–65.CrossRef

Titel: Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer
verfasst von: Eric Laffon
Roger Marthan
Publikationsdatum: 30.10.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-4201-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer

Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease

Improved beta-amyloid PET reproducibility using two-phase acquisition and grey matter delineation

Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders

Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18F]FDG PET

The good rays: let them shine!